Stock Report

All about this stock under one free report Last Updated: 01-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Genmab A/S ADS - ADR Peer Comparison

Stock Card factsheet share-fund-plan-icon

$33.16

up-down-arrow $-0.07 (-0.21%)

As on 31-Aug-2026 16:00EDT

Market cap

info icon

$20,720 Mln

Revenue (TTM)

info icon

$4,131 Mln

P/E Ratio

info icon

26.2

P/B Ratio

info icon

3.5

Div. Yield

info icon

0 %

Edit peer-selector-edit
Genmab A/S ADS - ADR argenx SE - ADR Zai Lab - ADR Mesoblast - ADR HUTCHMED (China) - ADR
Market cap ($ Mln)
 20,720 63,631 2,928 2,262 2,152
Revenue ($ Mln)
 4,131 8,446 450 120 549
Net Profit ($ Mln)
 788.10 2,595.76 -188.21 -57.50 17.88
Net Margin (%)
 19.08 30.73 -41.86 -144.33 3.26
RoE (%)
 13.37 32.98 -28.46 -9.86 1.43
Price to Earnings
 26.17 38.95 -- -- 123.80
Price-To-Book
 3.52 7.87 4.96 4.15 1.71

Income Statement ($ Mln)

Genmab A/S ADS - ADR argenx SE - ADR Zai Lab - ADR Mesoblast - ADR HUTCHMED (China) - ADR
Operating Revenue arrow
4,131.13 8,446.25 449.61 17.20 549.12
Cost of Revenue arrow
288.00 849.62 195.71 5.13 548.01
Gross Profit arrow
3,413.69 3,702.82 269.08 12.07 212.72
Operating Expenses arrow
2,509.03 5,385.48 517.90 74.51 35.89
Operating Profit (EBIT) arrow
1,334.10 2,441.58 -264.00 -62.44 -34.78
Other Income arrow
0.00 0.00 0.00 -- 0.00
Profit before Tax arrow
906.11 2,762.70 -190.72 -101.81 20.08
Provision for Tax arrow
118.01 64.15 -2.51 0.33 1.66
Profit after Tax (Net Income) arrow
788.10 2,595.76 -188.21 -102.14 17.88
Minority Interest arrow
0.00 0.00 0.00 -- 0.00
Consolidated Profit arrow
0.00 0.00 0.00 -- 0.00

Liabilities ($ Mln)

Genmab A/S ADS - ADR argenx SE - ADR Zai Lab - ADR Mesoblast - ADR HUTCHMED (China) - ADR
Shareholder's Funds arrow
5,957.00 8,417.00 607.04 597.44 1,260.78
Minority Interest arrow
0.00 0.00 0.00 -- 0.00
Non-Current Liabilities arrow
5,418.00 40.00 39.17 84.62 186.25
Current Liabilities arrow
1,140.00 1,575.00 428.58 102.63 275.21
Total Liabilities arrow
12,843.63 8,682.70 1,172.38 784.68 1,753.10

Assets ($ Mln)

Genmab A/S ADS - ADR argenx SE - ADR Zai Lab - ADR Mesoblast - ADR HUTCHMED (China) - ADR
Non-Current Assets arrow
9,714.00 1,964.00 160.76 580.33 183.02
Current Assets arrow
2,801.00 8,068.00 914.04 204.35 1,553.41
Total Assets arrow
12,843.63 8,682.70 1,172.38 784.68 1,753.10
Total Debt* arrow
5,273.00 47.00 254.58 128.16 94.51
Net Current Assets arrow
1,661.00 6,493.00 485.45 101.72 0.00

Cashflow ($ Mln)

Genmab A/S ADS - ADR argenx SE - ADR Zai Lab - ADR Mesoblast - ADR HUTCHMED (China) - ADR
Cash From Operating Activities arrow
1,186.94 850.49 -150.79 -49.95 -64.66
Cash Flow from Investing Activities arrow
-5,647.45 823.88 307.87 0.12 -29.41
Cash from Financing Activities arrow
4,792.78 233.73 72.35 147.34 7.84
Net Cash Inflow / Outflow arrow
-- -- -- -- --

Ratios

Profitability Ratios

 Genmab A/S ADS - ADR argenx SE - ADR Zai Lab - ADR Mesoblast - ADR HUTCHMED (China) - ADR
ROCE (%) arrow
3.93 19.96 -18.15 -15.42 41.92
ROE (%) arrow
13.37 32.98 -28.46 -18.95 1.43
ROA (%) arrow
7.60 26.19 -12.55 -14.05 0.66
EBIT Margin (%) arrow
21.54 21.80 -41.09 -- -6.33
Net Margin (%) arrow
19.08 30.73 -41.86 -593.92 3.26
Cash Profit Margin (%) arrow
0.00 -- 0.00 -- --

Growth Ratios

 Genmab A/S ADS - ADR argenx SE - ADR Zai Lab - ADR Mesoblast - ADR HUTCHMED (China) - ADR
Revenue Growth (%) arrow
-68.25 130.89 5.10 1.91 -8.81
EBIT Growth (%) arrow
-81.67 315.16 11.36 -- -76.55
Net Profit Growth (%) arrow
-85.61 89.22 11.44 -16.13 -96.17
EPS Growth (%) arrow
-85.16 98.91 -1.87 -0.02 -96.17
Book Value Growth (%) arrow
12.89 40.75 -25.05 -- 2.54

Valuation Ratios

 Genmab A/S ADS - ADR argenx SE - ADR Zai Lab - ADR Mesoblast - ADR HUTCHMED (China) - ADR
Price / Earnings arrow
21.49 43.09 -11.11 -13.58 5.08
Price / Book Value arrow
3.55 7.60 2.73 2.32 1.88
Dividend Yield (%) arrow
-- -- -- -- --
EV/EBITDA arrow
18.27 39.15 -9.39 -18.38 -25.58
Market Cap ($ Cr) arrow
-- -- -- -- --

Solvency Ratios

 Genmab A/S ADS - ADR argenx SE - ADR Zai Lab - ADR Mesoblast - ADR HUTCHMED (China) - ADR
Debt to Equity arrow
0.81 0.00 0.00 0.21 0.00
Short term debt to equity ratio arrow
0.05 0.00 0.40 0.10 0.02
Current Ratio arrow
2.46 5.12 2.13 1.99 5.64
Quick Ratio arrow
2.44 4.89 1.92 1.77 5.50
Interest Coverage arrow
4.36 554.10 -30.87 -3.49 -19.05

Operating Efficiency Ratios

 Genmab A/S ADS - ADR argenx SE - ADR Zai Lab - ADR Mesoblast - ADR HUTCHMED (China) - ADR
Debtors to sales (%) arrow
30.98 22.98 16.23 86.44 21.41
Asset Turnover arrow
0.40 0.85 0.30 0.02 0.20
Receivable days arrow
384.60 112.83 77.60 380.35 104.79
Inventory Days arrow
47.22 356.92 109.55 791.94 49.57
Payable days arrow
1,259.72 652.17 231.78 931.00 47.68
Cash Conversion Cycle arrow
-827.90 -182.43 -44.63 241.30 106.67
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...